United Therapeutics (UTHR) Stock Chart & Stock Price History $300.43 -1.07 (-0.35%) Closing price 08/11/2025 04:00 PM EasternExtended Trading$296.75 -3.68 (-1.22%) As of 08/11/2025 06:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock United Therapeutics Stock Price Performance The United Therapeutics (UTHR) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 9.99%, with a year-to-date return of -14.85%. In the past month, the stock has increased 1.66%, reflecting recent market activity. As of the latest close, United Therapeutics traded at $300.43 with a market cap of $13.55 billion and volume of 575,733 shares. Five years ago, the stock traded at $109.15, representing a 175.25% increase over that period. At the time, it had a market cap of $4.91 billion and a volume of 185,000 shares. Receive UTHR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for United Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.34%1 Month Performance+1.66%3 Month Performance-3.34%Year-To-Date Performance-14.85%1 Year Performance-9.99%5 Year Performance+175.25% UTHR Stock Chart for Tuesday, August, 12, 2025 UTHR Chart by TradingView United Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/11/2025$301.50$300.43-0.35%$306.00$300.24575,733 shs$13.55 billion08/08/2025$299.42$301.50+0.69%$305.36$297.38519,284 shs$13.60 billion08/07/2025$302.41$299.42-0.99%$304.77$296.57520,163 shs$13.51 billion08/06/2025$304.81$302.41-0.79%$307.06$299.45540,914 shs$13.64 billion08/05/2025$292.65$304.81+4.16%$307.49$291.221.14 million shs$13.75 billion08/04/2025$294.28$292.65-0.55%$294.34$287.64909,297 shs$13.20 billion08/01/2025$274.70$294.28+7.13%$296.60$283.012.43 million shs$13.27 billion07/31/2025$281.95$274.70-2.57%$284.00$272.12640,991 shs$12.39 billion07/30/2025$297.56$281.95-5.25%$300.49$280.351.02 million shs$12.72 billion07/29/2025$298.14$297.56-0.19%$302.14$296.85527,065 shs$13.42 billion Get the Latest News and Ratings for UTHR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for United Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/28/2025$304.50$298.14-2.09%$306.24$297.30497,311 shs$13.45 billion07/25/2025$306.41$304.50-0.62%$307.27$302.11310,921 shs$13.74 billion07/24/2025$305.61$306.41+0.26%$307.70$302.65403,405 shs$13.82 billion07/23/2025$297.89$305.61+2.59%$306.92$299.02431,075 shs$13.79 billion07/22/2025$293.12$297.89+1.63%$298.91$293.99372,402 shs$13.44 billion07/21/2025$292.01$293.12+0.38%$296.56$291.47279,827 shs$13.22 billion07/18/2025$297.33$292.01-1.79%$299.16$290.80322,671 shs$13.17 billion07/17/2025$298.16$297.33-0.28%$302.52$293.66459,518 shs$13.41 billion07/16/2025$293.24$298.16+1.68%$299.83$295.01324,808 shs$13.45 billion07/15/2025$297.68$293.24-1.49%$300.37$291.72303,168 shs$13.23 billion07/14/2025$295.52$297.68+0.73%$298.47$294.21313,920 shs$13.43 billion07/11/2025$300.16$295.52-1.55%$298.96$295.33300,699 shs$13.33 billion Related Companies BIIB Stock Price Chart INCY Stock Price Chart NBIX Stock Price Chart BMRN Stock Price Chart EXEL Stock Price Chart EXAS Stock Price Chart HALO Stock Price Chart MDGL Stock Price Chart IONS Stock Price Chart RGEN Stock Price Chart Receive UTHR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for United Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:UTHR) was last updated on 8/12/2025 by MarketBeat.com Staff From Our PartnersWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredWhy Elon put $51 million into thisChris Rowe has made legendary calls—Tesla at $13, Nvidia at $40, Bitcoin under $1,000, Amazon at 12 cents. Now...True Market Insiders | Sponsored#1 Pre-IPO Opportunity For 2025 [Take Action Now!]James Altucher has scored 37X and even 60X returns on past pre-IPO deals. But now he says a much bigger opport...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredSell these stocks now—what to buy insteadWall Street veteran Marc Chaikin—creator of the Power Gauge system—is warning that “smart money” is rapidly pu...Chaikin Analytics | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding United Therapeutics Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share United Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access